More articles from Commentary
- The underappreciated role of documentation in improving COPD care
Despite the importance of providing guideline-concordant care, there are still barriers to implementing evidence-based recommendations in providing care for patients with chronic obstructive pulmonary disease.
- Peyronie disease and erectile dysfunction: A potential new paradigm
Viewing Peyronie disease as related to erectile dysfunction allows for the possibility of preventing the disease in patients with erectile insufficiency.
- SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation
SGLT-2 inhibitors remain vastly underused in clinical practice despite their broad cardiorenal benefits.
- Another influenza season in the shadow of the COVID-19 pandemic
Flu season is upon us at the ominous milestone of more than 722,000 US deaths from COVID-19.
- Teriparatide: Label changes and identifying patients for long-term use
The changes leave clinicians with the challenge of identifying appropriate patients.
- Statin intolerance and new lipid-lowering treatments
The benefits and safety of statin therapy are clear, but adverse effects continue to pose diagnostic and therapeutic challenges.
- What is causing the ‘long-hauler’ phenomenon after COVID-19?
We are still early in our understanding of COVID-19 and its many manifestations.
- Our evolving understanding of primary aldosteronism
Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.
- Cleveland Clinic Journal of Medicine: Evolution and a look ahead
Cleveland Clinic is 100 years old and has had a medical journal for 90 of those years.
- COVID-19 diagnostic testing and the psychology of precautions fatigue
Overuse of special precautions can lead to diminished vigilance.